Klimas J, Fernandes E, DeBeck K, Hayashi K, Milloy MJ, Kerr T, Cullen W, Wood E Preliminary results and publication impact of a dedicated addiction clinician scientist research fellowship J Addict Med, 2017. PubMed


Kennedy MC, Kerr T Overdose prevention in the United States: a call for supervised injection sites Am J Public Health, 2017. PubMed


Tran M, Wood E, Kerr T, Patterson S, Bangsberg D, Dong H, Guillemi S, Montaner JSG, Milloy MJ Increases in CD4+ cell count at antiretroviral therapy initiation among HIV-positive illicit drug users during a treatment-as-prevention initiative in Canada Antivir Ther, 2017. PubMed


Luongo N, Dong H, Kerr T, Milloy MJ, Hayashi K, Richardson L Income generation and attitudes towards addiction treatment among people who use illicit drugs in a Canadian setting Addict Behav, 2017. PubMed


Nolan S, Klimas J, Wood E Alcohol use in opioid agonist treatment Addict Sci Clin Pract, 2016. PubMed


Socías ME, Ahamad K An urgent call to increase access to evidence-based opioid agonist therapy for prescription opioid use disorders CMAJ, 2016. PubMed


Socías ME, Volkow N, Wood E Adopting the ‘cascade of care’ framework: an opportunity to close the implementation gap in addiction care? Addiction, 2016. PubMed


Zivanovic R, Wood E, Nolan S Naloxone infusion in the setting of an unknown ingestion: a case report Can J Addict, 2016. Link


Rieb LM, Norman WV, Martin RE, Berkowitz J, Wood E, McNeil R, Milloy MJ Withdrawal-associated injury site pain (WISP): a descriptive case series of an opioid cessation phenomenon Pain, 2016. PubMed


Lake S, Milloy MJ, Dong H, Hayashi K, Wood E, Kerr T, DeBeck K Initiation into prescription opioid injection and associated trends in heroin use among people who use illicit drugs Drug Alcohol Depend, 2016. PubMed